『Lung Cancer Update』のカバーアート

Lung Cancer Update

Lung Cancer Update

著者： Dr. Neil Love
無料で聴く

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.Copyright 2025 Research To Practice. All Rights Reserved 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

    Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies
    2026/10/17

    Featuring a slide presentation from Dr Julia Rotow, including the following topics:

    • Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00)
    • Key findings from the Phase III HARMONi-6 study; ongoing Phase III HARMONi-3 study (5:12)
    • Key findings from the Phase III HARMONi-2 study; ongoing Phase III HARMONi-7 study (9:59)
    • Clinician insights about the potential role of ivonescimab in the front-line setting (12:02)
    • Impetus for investigating ivonescimab in the relapsed/refractory (R/R) EGFR-mutant setting (14:01)
    • Key findings from the Phase III HARMONi-A and HARMONi studies (16:07)
    • Clinician insights about the potential role of ivonescimab in the treatment of R/R EGFR-mutant NSCLC; other novel PD-1/PD-L1 x VEGF bispecific antibodies under investigation (20:30)

    CME information and select publications
    続きを読む 一部表示
    24 分
  • Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

    Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
    2026/10/04

    Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:

    • Introduction (0:00)
    • EGFR Mutations (2:23)
    • HER2 Alterations (22:40)
    • Available and Investigational Immunotherapies (32:14)
    • Small Cell Lung Cancer (40:48)

    CME information and select publications
    続きを読む 一部表示
    51 分
  • For Oncology Nurses: Non-Small Cell Lung Cancer with a ROS1 Fusion — An Interview with Dr Alexander E Drilon

    For Oncology Nurses: Non-Small Cell Lung Cancer with a ROS1 Fusion — An Interview with Dr Alexander E Drilon
    2026/09/30

    Featuring an interview with Dr Alexander E Drilon, including the following topics:

    • Overview of targetable biomarkers in lung cancer (0:00)
    • Biomarker testing for genomic alterations in lung cancer (5:24)
    • Overview of ROS1 alterations in lung cancer (13:44)
    • Efficacy data with ROS1 inhibitors for lung cancer (17:02)
    • Safety data with ROS1 inhibitors for lung cancer (21:15)
    • Case: A woman in her early 50s with a history of non-small cell lung cancer (NSCLC) undergoes biomarker testing to reveal a ROS1 fusion (28:56)
    • Case: A man in his late teens diagnosed with de novo advanced NSCLC with a ROS1 alteration achieves a dramatic response to therapy (46:16)
    • Case: A woman in her early 60s with a history of ROS1-altered NSCLC receives several ROS1 inhibitors (50:52)

    NCPD information and select publications
    続きを読む 一部表示
    58 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません